The miR-200 family as prognostic markers in clear cell renal cell carcinoma

被引:33
作者
Saleeb, Rola [1 ]
Kim, Sung Sun [1 ,2 ,3 ]
Ding, Qiang [2 ]
Scorilas, Andreas [4 ]
Lin, Sicheng [1 ]
Khella, Heba W. Z. [1 ]
Boulos, Carl [1 ,2 ]
Ibrahim, Gena [1 ]
Yousef, George M. [1 ,2 ]
机构
[1] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[2] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON, Canada
[3] Chonnam Natl Univ, Dept Pathol, Med Sch, Gwangju, South Korea
[4] Univ Athens, Dept Biochem & Mol Biol, Athens, Greece
关键词
Renal Cell Carcinoma; MicroRNAs; Prognosis; Biomarkers; EPITHELIAL-MESENCHYMAL TRANSITION; CLASSIFICATION; IDENTIFICATION; PROGRESSION; METASTASIS; TARGETS; MIR-141;
D O I
10.1016/j.urolonc.2019.08.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: microRNAs (miRNAs) are small noncoding RNAs that regulate gene expression by mRNA cleavage or translational repression. The miR-200 family is involved in the regulation of various tumor biologic processes including apoptosis, proliferation, invasion, and metastasis. They function mainly as tumor suppressors. In this study, we aim to validate the prognostic significance of miR-200 family using large cohort of primary clear cell renal cell carcinoma (ccRCC) and matched normal tissue and to explore the role of miR-200 family in RCC pathogenesis and progression. Materials and Methods: We analyzed the expression of 3 members of the miR-200 family; miR-141, miR-200b, and miR-200c, between primary ccRCC, matched normal renal tissues, and nonmatched metastatic RCC. We compared clinicopathologic parameter including disease-free survival to miR-200 family expression. Additionally, we validated our results using The Cancer Genome Atlas dataset. We explored functional role of these miRNAs by bioinformatics analyses. Results and Conclusions: Expression of miR-200 family significantly decreased in cancer compared to non-neoplastic tissues. miR-141 and miR-200b were significantly down-regulated in metastatic than primary tumors. There was statistically significant negative association between all 3 miRNAs and tumor size and stage. As binary variables, univariate analyses revealed that miR-141, miR-200b, and miR-200c-positive ccRCC patients have a statistically significant lower chance of disease-recurrence or relapse and multivariate analyses showed miR-200b and miR-200c-positive patients have longer disease-free survival. We could predict disease-free survival better when 2 or more miRNAs were used as a combination. Overall survival analysis using The Cancer Genome Atlas data revealed that miR-200b-positive patients have significantly better survival. These results suggest that miR-141, miR-200b, and miR-200c are independent prognostic markers for ccRCC. Targets of these miRNAs are associated with pathways related to cancer invasion and metastasis, including TRAIL pathway, VEGF and VEGFR signaling network, and epithelial-mesenchymal transition. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:955 / 963
页数:9
相关论文
共 29 条
[1]  
[Anonymous], 2016, WHO classification of tumours of the urinary system and male genital organs
[2]   Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma [J].
Butz, Henriett ;
Nofech-Mozes, Roy ;
Ding, Qiang ;
Khella, Heba W. Z. ;
Szabo, Peter M. ;
Jewett, Michael ;
Finelli, Antonio ;
Lee, Jason ;
Ordon, Michael ;
Stewart, Robert ;
Krylov, Sergey ;
Yousef, George M. .
EUROPEAN UROLOGY FOCUS, 2016, 2 (02) :210-218
[3]   miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression [J].
Chen, Xuanyu ;
Wang, Xuegang ;
Ruan, Anming ;
Han, Weiwei ;
Zhao, Yan ;
Lu, Xing ;
Xiao, Pei ;
Shi, Hangchuan ;
Wang, Rong ;
Chen, Li ;
Chen, Shaoyong ;
Du, Quansheng ;
Yang, Hongmei ;
Zhang, Xiaoping .
CLINICAL CANCER RESEARCH, 2014, 20 (10) :2617-2630
[4]   A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization [J].
Di Meo, Ashley ;
Saleeb, Rola ;
Wala, Samantha J. ;
Khella, Heba W. ;
Ding, Qiang ;
Zhai, Haiyan ;
Krishan, Kalra ;
Krizova, Adriana ;
Gabril, Manal ;
Evans, Andrew ;
Brimo, Fadi ;
Pasic, Maria D. ;
Finelli, Antonio ;
Diamandis, Eleftherios P. ;
Yousef, George M. .
ONCOTARGET, 2018, 9 (02) :2092-2104
[5]   miRWalk2.0: a comprehensive atlas of microRNA-target interactions [J].
Dweep, Harsh ;
Gretz, Norbert .
NATURE METHODS, 2015, 12 (08) :697-697
[6]   Most mammalian mRNAs are conserved targets of microRNAs [J].
Friedman, Robin C. ;
Farh, Kyle Kai-How ;
Burge, Christopher B. ;
Bartel, David P. .
GENOME RESEARCH, 2009, 19 (01) :92-105
[7]   Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal [J].
Gao, Jianjiong ;
Aksoy, Buelent Arman ;
Dogrusoz, Ugur ;
Dresdner, Gideon ;
Gross, Benjamin ;
Sumer, S. Onur ;
Sun, Yichao ;
Jacobsen, Anders ;
Sinha, Rileen ;
Larsson, Erik ;
Cerami, Ethan ;
Sander, Chris ;
Schultz, Nikolaus .
SCIENCE SIGNALING, 2013, 6 (269) :pl1
[8]   The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy [J].
Humphries, Brock ;
Yang, Chengfeng .
ONCOTARGET, 2015, 6 (09) :6472-6498
[9]   Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points [J].
Lee, L. ;
Wang, L. ;
Crump, M. .
ANNALS OF ONCOLOGY, 2011, 22 (06) :1392-1403
[10]   Glypican-1 Promotes Tumorigenesis by Regulating the PTEN/Akt/-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma [J].
Li, Jing ;
Chen, Yanjie ;
Zhan, Cheng ;
Zhu, Jimin ;
Weng, Shuqiang ;
Dong, Ling ;
Liu, Taotao ;
Shen, Xizhong .
DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (06) :1493-1502